VC
Veracyte
VCYT·NASDAQS San Francisco CAFounded 2008900 employees
Mid CapbiotechPublicOncology
Platform: Genomic Dx Classifier
Market Cap
$3B
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (VCYT)
Loading VCYT stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gozesotorasib | VCY-8663 | Phase 1/2 | 2 | BET | HCC | ||
| VCY-7974 | VCY-7974 | Phase 1 | 2 | CD20 | ThymomaEoE | ||
| VCY-7977 | VCY-7977 | Phase 3 | 1 | RET | Ewing SarcomaMG |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)